TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06223191

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brief Negotiated Interview
Description: The BNI is a specialized brief intervention for the medical setting, has foundations in motivational interviewing techniques. The BNI helps health care providers explore health behavior change with patients in a respectful, non-judgmental way within a finite time period. The BNI is in the form of an algorithm, or script, that guides providers through the health intervention with carefully phrased key questions and responses, all at the providers' fingertips

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Narrative Interview
Description: The Narrative Interview is a therapeutic approach that aims to motivate the individual's conscious and transformative knowledge, skills, and capabilities. This interview is based on the technical components of narrative therapy, where the patient narrates their story, using externalizing language and considering social and political aspects related to the issue. It will focus on exploring past and present feelings, thoughts, and actions.
Study: NCT04609904

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BGF MDI 320/28.8/9.6 μg
Description: Budesonide, glycopyrronium, and formoterol fumarate metered dose inhaler

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BGF MDI 320/14.4/9.6 μg
Description: Budesonide, glycopyrronium, and formoterol fumarate metered dose inhaler

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BFF MDI 320/9.6 μg
Description: Budesonide and formoterol fumarate metered dose inhaler

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BFF pMDI 320/9 μg
Description: Budesonide/formoterol fumarate pressurized metered dose inhaler
Study: NCT04694963

Intervention type: PROCEDURE
Intervention: Blood sample
Description: 2 ml venous blood was collected and separated into serum.

Intervention type: PROCEDURE
Intervention: Data collection
Description: 1. Whether the patient has been vaccinated with DPT vaccine and record the time of vaccination;~2. Medication situation of patients in the past year, including rescue drugs, antitussive and expectorant drugs, inhaled corticosteroids and antibiotics;

Intervention type: PROCEDURE
Intervention: Throat swab
Description: Before the collection of oropharyngeal swabs, instruct the patient to wash the mouth or gargle, fix the patient's head, open the mouth and expose the throat. If necessary, use a tongue depressor to gently press the tongue.~Use the swab to wipe the secretion on both sides of the palatal arch, pharynx and tonsil with a sensitive and gentle action, and quickly withdraw the swab to avoid contacting other parts of the mouth.~Put the swab in the sterile test tube, plug the opening with cotton ball, and send it for inspection and registration in time.
Study: NCT06261957

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Salbutamol HFA-134a
Description: 100 microgram (μg) (ex-valve) at 30-second intervals per actuation

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salbutamol HFA-152a
Description: 100 μg (ex-valve) at 30-second intervals per actuation
Study: NCT05362019

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Compound Norethisterone Enanthate Injection
Description: Combined injectable contraceptive use
Study: NCT06297863

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: HEAD DOWN TILT -10° to -15°
Description: Head down tilt -10° to -15° (HDT15) is a positional therapy consisting of tilting the patient with the head -10° to -15° degrees below the rest of the body.~Application of HDT15 will not delay usual care. The standard in-hospital patient pathway, including transfer from neuroimaging room to the angiography suite and the required procedural steps of MT, will allow sufficient time for the application of HDT15. HDT15 duration is expected to be at least 30 minutes (estimated time 30 to 90 minutes), from start to the assessment of the primary efficacy endpoint.~The actual degree of HDT15 will be a range between -10° to -15°, depending on the angiographic system of each clinical site, but it will be maintained at -15° during the Emergency Room phase which is expected to account for \>50% of the total application time.
Study: NCT04974684

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HeartMate 3
Description: Patients implanted with HeartMate 3 will be randomized in 2:1 ratio in interventional and control group. Patients in interventional group will be switched to therapy with apixaban instead of warfarin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: Patients implanted with HeartMate 3 will be randomized in 2:1 ratio in interventional and control group. Patients in interventional group will be switched to therapy with apixaban instead of warfarin.
Study: NCT04964440

Intervention type: DEVICE
Intervention: Pure-EP
Description: Advanced Signal Acquisition and Processing
Study: NCT05957549

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Speech discrimination
Description: Two different speech sounds are played at the same sound intensity.
Study: NCT06402799

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based E-biking
Description: The e-biking intervention consists of 3 sessions per week at the beginning of the study and gradually increases over the training period to 6 sessions per week, with three of these sessions being online and group-supervised. Heart rate will be monitored as well as power in Watt at each session.
Study: NCT06092671

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Family-centred perioperative care for anaesthesia
Description: The patient in intervention group and parent will receive the Family-centred perioperative care for anaesthesia, including video education, anaesthesia mask practice, electronic pamphlet, distraction strategies and parental presence. The patient will not receive sedatives before surgery. During the anesthesia induction period, it is recommended that the parent be instructed by the anesthesiologist to complete the induction of inhalation of the anesthesia mask, and the patient will be accompanied by the parent during the awakening period.
Study: NCT05362019

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Compound Norethisterone Enanthate Injection
Description: Combined injectable contraceptive use

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: One-to-one Service
Description: A mobile phone based service system will be used to pushing contraceptive knowledges, reminding injection, providing consultation on adverse reactions and ect.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Family Planning Service
Description: routine family planning service and contraceptive service.
Study: NCT06310668

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: group cognitive behavioral therapy sessions
Description: 12 group CBT sessions based on catching and challenging cognitive errors and behavioral techniques to deal with substance use problems
Study: NCT04764253

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified Sodium Watcher Program + Digital Self-Monitoring
Description: Participants randomized to the experimental group will be asked to follow the modified Sodium Watchers Program intervention along with goal setting for low salt foods. Each participant will be registered to assign a unique ID in the Connected Health Platform developed by the Center on Smart and Connected Health Technologies at UT Health Science Center San Antonio and each account from the individuals' wireless and wearable devices (Fitbit and BP monitor) will be connected to his or her unique ID through this platform. Participants will be instructed to log their activities in real-time, including food intake and in-home BP monitoring using Fitbit and accompanied mobile app and BP monitor. Through the Connected Health Platform, the Fitbit app and BP monitor will transmit the data of the intervention group to the research team.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care + Digital Self-Monitoring
Description: Participants randomized to the control group will be asked to follow usual care which is based on their routine medical and nursing care for hypertension that consists of a recommendation to follow a sodium-restricted diet and take medications as prescribed. The participants will receive wireless and wearable devices (Fitbit wristband, BP monitor). Each participant will be registered to assign a unique ID in the Connected Health Platform at the baseline and each account from the individual's wireless and wearable devices (Fitbit and BP monitor) will be connected to their unique ID through this platform. Participants will be instructed to log their activities in real-time, including food intake and in-home BP monitoring using Fitbit and accompanied mobile app and BP monitor.
Study: NCT06414122

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mid-frequency whole-body electromyostimulation (WB-EMS)
Description: supervised group training sessions at least once and optionally twice a week, lasting 11-20 minutes, over 12 weeks, 12-24 training sessions in total

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional exercise training
Description: supervised group training at least once a week, optional additional home-based training once a week, lasting 40 minutes, over 12 weeks, 12-24 training sessions in total
Study: NCT06268119

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: training nurses and caring for patients to prevent, diagnose, and intervene in postoperative delirium.
Description: The intervention group received care in line with the postoperative delirium prevention, diagnosis and intervention protocol after the delirium training given by the researcher to intensive care unit nurses.
Study: NCT05415384

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryoablation of Intercostal Nerves
Description: Using Atricure device, cryoice, intercostal nerves 3-8 will be ablated in the experimental arm. This is in addition to mechanical fixation of rib fractures and multimodal systemic therapy.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard surgical treatment of patients with multiple rib fractures
Description: Standard surgical treatment of patients with multiple rib fractures
Study: NCT06414122

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: nutritional therapy
Description: conventional nutritional counselling with guidelines and digital nutritional coaching

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nutritional therapy
Description: conventional nutritional counselling with guidelines and digital nutritional coaching
Study: NCT05835258

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Melatonin with phenyl capsaicin
Description: Blood samples will be collected at different time points following the oral administration of the melatonin supplement with phenyl capsaicin

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Melatonin without phenyl capsaicin
Description: Blood samples will be collected at different time points following the oral administration of the melatonin supplement without phenyl capsaicin
Study: NCT06292312

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Craniosacral therapy
Description: Craniosacral therapy is defined as an alternative, massage-like treatment approach using gentle manual force to address somatic dysfunctions of the head and the rest of the body.
Study: NCT05763537

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard Doula Care Plus PMAD Intervention
Description: Doulas trained in the DONA training, and the PMAD-focused training will provide care to perinatal people.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard Doula Care
Description: Doulas trained in the DONA training will provide care to perinatal people.
Study: NCT05831657

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prevent It 2.0
Description: A free, anonymous, internet-delivered, therapist assisted, cognitive behavioral therapy (CBT) intervention

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prevent It 2.0
Description: A free, anonymous, internet-delivered, therapist assisted, cognitive behavioral therapy (CBT) intervention

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prevent It 2.0
Description: A free, anonymous, internet-delivered, therapist assisted, cognitive behavioral therapy (CBT) intervention

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Waitlist
Description: Participants in the waitlist control will wait thirteen weeks before starting active treatment. While on the waitlist, participants will respond to questions about ongoing problematic sexual behavior.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Waitlist
Description: Participants in the waitlist control will wait thirteen weeks before starting active treatment. While on the waitlist, participants will respond to questions about ongoing problematic sexual behavior.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Waitlist
Description: Participants in the waitlist control will wait thirteen weeks before starting active treatment. While on the waitlist, participants will respond to questions about ongoing problematic sexual behavior.
Study: NCT05212350

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total pancreatectomy
Description: Patients randomized to receive total pancreatectomy at the time of transection of the pancreas will undergo completion total pancreatectomy according to each Institution's operative standards.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pancreatic anastomosis
Description: Patients randomized to receive pancreatic anastomosis at the time of transection of the pancreas will undergo pancreatico-jejunosomy or pancreatico-gastrostomy according to each Institution's operative standards.
Study: NCT02651506

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electromagnetic Navigation Bronchoscopy
Description: • Participants randomized to the intervention arm will undergo biopsy using the superDimension®InReach™ System. Participants will undergo ENB guided biopsy under general anesthesia or local anesthesia. The procedure will be performed by a thoracic surgeon in the operating room or endoscopy suite. Following electromagnetic mapping, bronchoscopy and biopsy will be performed. Fiducial markings will be placed when necessary.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transthoracic Needle Biopsy
Description: • Patients randomized to the control arm (TTNB) will undergo lung biopsy using standard transthoracic needle biopsy technique. The procedure will be performed under local anesthesia with computed tomography guidance by an interventional radiologist. In this procedure, a CT-image is used to locate the area for biopsy. Once identified, the radiologist applies a local anesthetic and inserts an aspiration needle between the ribs, through normal lung tissue, leading into the biopsy area. The sampled lung tissue is then sent for pathological analysis.
Study: NCT06510309

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: B-cell lymphoma inhibitor, tablets taken orally per protocol.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Anti-CD20 monoclonal antibody, 10mL or 50 mL single-use vials, via intravenous (into the vein) infusion per protocol.
Study: NCT06292312

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physiotherapy
Description: Range of motion, stretching, resistance exercises. Spasticity inhibition Balance and coordination exercises Walking training Stabilization exercises Breathing exercises

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy
Description: Range of motion, stretching, resistance exercises. Spasticity inhibition Balance and coordination exercises Walking training Stabilization exercises Breathing exercises
Study: NCT05296057

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Participants Receiving VR-Exposure Therapy Treatment
Description: In the baseline interview with an exposure therapy specialist and a member of the research team, participants will be presented with approximately three sets of possible exposure scenarios, each associated with approximately three different scenes that increase in severity level. Through discussion with the exposure therapy specialist, the participant will choose the exposure scenario (out of the three options) that most closely resembles their own epilepsy- or seizure-related fears. As the treatment, the participant will be exposed to the scenes that are associated with their chosen exposure set in a hierarchical manner using an immersive head-mounted display. The participant will work through the three levels of the chosen exposure scenario for approximately two weeks, ideally on each level for four days.
Study: NCT06252337

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bioceramic sealer group
Description: epoxy resin based + carrier based technique group. The sealer was inserted in the canal and the carrier was warmed in a dedicated oven (thermaprep) and inserted within 60 seconds.

Intervention type: OTHER
Group type: OTHER
Intervention: bioceramic sealer group
Description: epoxy resin based + carrier based technique group. The sealer was inserted in the canal and the carrier was warmed in a dedicated oven (thermaprep) and inserted within 60 seconds.
Study: NCT06280105

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab+regorafenib
Description: cadonilimab: 6mg/kg iv D1 Q2W; regorafenib: 80mg QD oral; Eligible patients will receive cadonilimab combined with regorafenib, until disease progression or intolerable toxicity or death or withdrawal of informed consent, whichever occurred first
Study: NCT05417256

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tappa Endobronchial Blocker
Description: After intubation, the Tappa bronchial blocker will be advanced either through the intubation tube or outside the tube using a fiberoptic broncoscope. Once the position of the blocker is confirmed, the cuff of the blocker will be inflated with 1-3 mL of air. Since Tappa blocker has an autoinflation system, the anaesthetist can both inflate the cuff with one hand and operate the fiberoptic broncoscope at the same time.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Arndt Endobronchial Blocker
Description: After intubation, the endobronchial blocker will be passed through a multiport airway adapter that is placed at the proximal end of the tracheal tube.The fiberoptic broncoscope will be passed through the port and then through the guidewire loop at the end of the blocker. The bronchial blocker and the broncoscope will be advanced as a single unit into the target part of a right or left lung. The broncoscope will be withdrawn into the trachea and the blocker cuff will be inflated and the position of the blocker will be confirmed using the fiberoptic broncoscope. The wire loop will be removed after correct placement of the blocker. Once the guide wire is removed, the blocker can't be replaced.
Study: NCT06251427

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Multiple micronutrient fortified maize with milk
Description: The study product is a multiple micronutrient fortified maize pap with milk

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Multiple micronutrient fortified maize with milk
Description: The study product is a multiple micronutrient fortified maize pap with milk

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Multiple micronutrient fortified maize with milk
Description: The study product is a multiple micronutrient fortified maize pap with milk
Study: NCT04783675

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab (375 mg/m2) will be given as a single intravenous infusion after remission
Study: NCT04902352

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: No Periadventitial dissection of the SMA
Description: lymphoneural tissue around SMA left intact

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Periadventitial dissection of the SMA
Description: For the patients randomised for peri-adventitial dissection the right side of the SMA should be completely clear from lymphoneural tissue for at least 180 degrees on right side and from angle of the artery to the level of inferior border of the uncinate process. In the presence of an accessory or replaced right hepatic artery the peri-adventitial dissection should also be carried out around this vessel as well.
Study: NCT06255171

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Reading journalistic posts and articles on social media on nature
Description: Reading journalistic posts and articles, published on social media, regarding nature.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reading journalistic posts and articles on social media on deaths by suicide
Description: Reading journalistic posts and articles, published on social media, regarding deaths by suicide.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Reading journalistic posts and articles on social media on traffic-related deaths
Description: Reading journalistic posts and articles, published on social media, regarding traffic-related deaths
Study: NCT05277896

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: Intravenous ketamine as the sedative for induction of anesthesia during emergency tracheal intubation

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Etomidate
Description: Intravenous etomidate as the sedative for induction of anesthesia during emergency tracheal intubation
Study: NCT04504747

Intervention type: OTHER
Intervention: molecular analysis of blood and tumor
Description: RNAseq, DNAseq, CTCs

Intervention type: OTHER
Intervention: molecular analysis of blood and tumor
Description: RNAseq, DNAseq, CTCs

Intervention type: OTHER
Intervention: molecular analysis of blood and tumor
Description: RNAseq, DNAseq, CTCs
Study: NCT06556017

Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnosis of SSI
Description: Comparison of the manual system and ChatGPT for SSI diagnosis in colorectal surgery procedures enrolled in the SSI surveillance programme.
Study: NCT05593640

Intervention type: OTHER
Intervention: biological samples
Description: blood and synovial liquid will be sampled
Study: NCT05150470

Intervention type: OTHER
Group type: OTHER
Intervention: prevention
Description: dental digital fingerprinting
Study: NCT05696158

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MHNA-003
Description: MHNA-003 is a self-guided digital program for people living with tinnitus
Study: NCT06024265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ER2001 injection
Description: The minimum initial dose is 0.04mg/kg, then escalate to 0.08mg/kg, 0.16mg/kg and 0.32mg/kg. The planned duration of the treatment is 14 weeks, and ER2001 will be administrated intravenously at the first day of weeks 1, 3, 4, 5, 6, 7, 8, and 14.